Change - Announcement of Appointment::Appointment of Group Financial Controller and Company Secretary

Issuer & Securities

Issuer/ Manager
AJJ MEDTECH HOLDINGS LIMITED
Securities
AJJ MEDTECH HOLDINGS LIMITED - SG0584008601 - 584
Stapled Security
No

Announcement Details

Announcement Title
Change - Announcement of Appointment
Date &Time of Broadcast
09-Sep-2025 17:43:31
Status
New
Announcement Sub Title
Appointment of Group Financial Controller and Company Secretary
Announcement Reference
SG250909OTHRT0S4
Submitted By (Co./ Ind. Name)
Zhao Xin
Designation
Chief Executive Officer and Executive Director
Description (Please provide a detailed description of the event in the box below)
Appointment of Mr. Tan Kee Hong ("Mr. Tan") as Group Financial Controller and Company Secretary.

This announcement has been reviewed by the Company's sponsor, Evolve Capital Advisory Private Limited ("Sponsor"). It has not been examined or approved by the Singapore Exchange Securities Trading Limited (the "SGX-ST"), and the SGX-ST assumes no responsibility for the contents of this announcement, including the correctness of any of the statements or opinions made or reports contained in this announcement.

The contact person for the Sponsor is Mr. Jerry Chua (Tel: (65) 6241 6626) at 160 Robinson Road, #20-01/02, SBF Building, Singapore 068914.

Additional Details

Date Of Appointment
09/09/2025
Name Of Person
Tan Kee Hong
Age
33
Country Of Principal Residence
Singapore
The Board's comments on this appointment (including rationale, selection criteria, board diversity considerations, and the search and nomination process)
Mr. Tan's qualifications and experience position him to effectively lead the Company's finance, accounting, tax, and risk management functions, as well as oversee compliance matters. He has consistently demonstrated integrity, competence, a strong sense of responsibility, and alignment with the Company's values of fairness, transparency, professionalism, and integrity. On this basis, management is recommending his confirmation and promotion.

Considering the recommendations by the management team and Nominating Committee, the Board of Directors approved the appointment of Mr. Tan as an executive officer of the Company.
Whether appointment is executive, and if so, the area of responsibility
Mr. Tan has been appointed as Group Financial Controller with overall responsibility for finance, accounting, compliance, and reporting functions.

- Report directly to the CEO, Audit Committee and Board of Directors on financial compliance, governance, and statutory reporting matters, ensuring timely updates and full transparency.
- Ensure full compliance with SGX regulations, statutory financial reporting, corporate governance standards, and internal control frameworks.
- Lead the preparation and review of statutory reports, annual/quarterly/half-yearly financial statements, sustainability reports, and AGM/Board papers.
- Act as the primary liaison with regulators, auditors, financial institutions, and other relevant external stakeholders.
- Provide financial analysis, budgeting, and forecasting to support strategic and operational decision-making.
- Oversee day-to-day financial operations, including cash flow, collections, payroll, and administrative controls.
- Drive continuous improvement of financial systems, reporting processes, and efficiency measures.
- Lead and mentor the finance team, ensuring professional development and accountability.
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
Group Financial Controller and Company Secretary
Professional qualifications
Bachelor of Commerce (Honours) Accounting - Universiti Tunku Abdul Rahman
Any relationship (including immediate family relationships) with any existing director, existing executive officer, the issuer and/ or substantial shareholder of the listed issuer or any of its principal subsidiaries
Nil
Conflict of interests (including any competing business)
Nil
Working experience and occupation(s) during the past 10 years
1) Foo Kon Tan LLP, Audit Manager, from April 2020 to September 2024
2) UHY Lee Seng Chan, Audit Senior, from December 2017 to Feb 2020
3) Teo Liang Chye PAC, Audit Associate, from July 2014 to November 2017
Undertaking submitted to the listed issuer in the form of Appendix 7.7 (Listing Rule 704(7)) Or Appendix 7H (Catalist Rule 704(6))
Yes
Shareholding interest in the listed issuer and its subsidiaries?
No
# These fields are not applicable for announcements of appointments pursuant to Listing Rule 704 (9) or Catalist Rule 704 (8).
Past (for the last 5 years)
Nil
Present
AJJ Medtech Holdings Limited
(a) Whether at any time during the last 10 years, an application or a petition under any bankruptcy law of any jurisdiction was filed against him or against a partnership of which he was a partner at the time when he was a partner or at any time within 2 years from the date he ceased to be a partner?
No
(b) Whether at any time during the last 10 years, an application or a petition under any law of any jurisdiction was filed against an entity (not being a partnership) of which he was a director or an equivalent person or a key executive, at the time when he was a director or an equivalent person or a key executive of that entity or at any time within 2 years from the date he ceased to be a director or an equivalent person or a key executive of that entity, for the winding up or dissolution of that entity or, where that entity is the trustee of a business trust, that business trust, on the ground of insolvency?
No
(c) Whether there is any unsatisfied judgment against him?
No
(d) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving fraud or dishonesty which is punishable with imprisonment, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such purpose?
No
(e) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such breach?
No
(f) Whether at any time during the last 10 years, judgment has been entered against him in any civil proceedings in Singapore or elsewhere involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or a finding of fraud, misrepresentation or dishonesty on his part, or he has been the subject of any civil proceedings (including any pending civil proceedings of which he is aware) involving an allegation of fraud, misrepresentation or dishonesty on his part?
No
(g) Whether he has ever been convicted in Singapore or elsewhere of any offence in connection with the formation or management of any entity or business trust?
No
(h) Whether he has ever been disqualified from acting as a director or an equivalent person of any entity (including the trustee of a business trust), or from taking part directly or indirectly in the management of any entity or business trust?
No
(i) Whether he has ever been the subject of any order, judgment or ruling of any court, tribunal or governmental body, permanently or temporarily enjoining him from engaging in any type of business practice or activity?
No
(j) Whether he has ever, to his knowledge, been concerned with the management or conduct, in Singapore or elsewhere, of the affairs of :-
(i) any corporation which has been investigated for a breach of any law or regulatory requirement governing corporations in Singapore or elsewhere; or
No
(ii) any entity (not being a corporation) which has been investigated for a breach of any law or regulatory requirement governing such entities in Singapore or elsewhere; or
No
(iii) any business trust which has been investigated for a breach of any law or regulatory requirement governing business trusts in Singapore or elsewhere; or
No
(iv) any entity or business trust which has been investigated for a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, in connection with any matter occurring or arising during that period when he was so concerned with the entity or business trust?
No
(k) Whether he has been the subject of any current or past investigation or disciplinary proceedings, or has been reprimanded or issued any warning, by the Monetary Authority of Singapore or any other regulatory authority, exchange, professional body or government agency, whether in Singapore or elsewhere?
No
Any prior experience as a director of an issuer listed on the Exchange?
No
If no, please state if the director has attended or will be attending training on the roles and responsibilities of a director of a listed issuer as prescribed by the Exchange
Not Applicable